Citation: | ZHAO Xinyue, MA Hualin, SUN Liping, ZHANG Xinzhou, . Tubulointerstitial nephritis and uveitis syndrome: a review[J]. Chinese Journal of General Practice, 2023, 21(4): 659-662. doi: 10.16766/j.cnki.issn.1674-4152.002954 |
[1] |
AMARO D, CARREÑO E, STEEPLES L R, et al. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a review[J]. Br J Ophthalmol, 2020, 104(6): 742-747. doi: 10.1136/bjophthalmol-2019-314926
|
[2] |
ABRAHAM G, AGARWAL S K, GOWRISHANKAR S, et al. Chronic kidney disease of unknown etiology: hotspots in India and other Asian countries[J]. Semin Nephrol, 2019, 39(3): 272-277. doi: 10.1016/j.semnephrol.2019.02.005
|
[3] |
REGUSCI A, LAVA S A G, MILANI G P, et al. Tubulointerstitial nephritis and uveitis syndrome: a systematic review[J]. Nephrol Dial Transplant, 2022, 37(5): 876-886. doi: 10.1093/ndt/gfab030
|
[4] |
CARVALHO T J, CALÇA R, CASSIS J, et al. Tubulointerstitial nephritis and uveitis syndrome in a female adult[J]. BMJ Case Rep, 2019, 12(1): e227688. DOI: 10.1136/bcr-2018-227688.
|
[5] |
OKAFOR L O, HEWINS P, MURRAY P I, et al. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors[J]. Orphanet J Rare Dis, 2017, 12(1): 128. doi: 10.1186/s13023-017-0677-2
|
[6] |
KANNO H, ISHIDA K, YAMADA W, et al. Clinical and genetic features of tubulointerstitial nephritis and uveitis syndrome with long-term follow-up[J]. J Ophthalmol, 2018, 2018: 4586532. DOI: 10.1155/2018/4586532.
|
[7] |
MACKENSEN F, DAVID F, SCHWENGER V, et al. HLA-DRB1*0102 is associated with TINU syndrome and bilateral, sudden-onset anterior uveitis but not with interstitial nephritis alone[J]. Br J Ophthalmol, 2011, 95(7): 971-975. doi: 10.1136/bjo.2010.187955
|
[8] |
REDDY A K, HWANG Y S, MANDELCORN E D, et al. HLA-DR, DQ class II DNA typing in pediatric panuveitis and tubulointerstitial nephritis and uveitis[J]. Am J Ophthalmol, 2014, 157(3): 678-86. e1-2. doi: 10.1016/j.ajo.2013.12.006
|
[9] |
LOPES B O, BRÍZIDO M S, COSTA A C, et al. Tubulointerstitial nephritis and uveitis syndrome: case series and literature review[J]. Case Rep Ophthalmol Med, 2021, 2021: 1812271. DOI: 10.1155/2021/1812271.
|
[10] |
CARAVACA-FONTÁN F, SHABAKA A, SÁNCHEZ-ÁLAMO B, et al. Recurrent acute interstitial nephritis: what lies beneath[J]. Clin Kidney J, 2021, 14(1): 197-204. doi: 10.1093/ckj/sfaa018
|
[11] |
KOLOMEYER A M, KODATI S. Lamotrigine-induced tubulointerstitial nephritis and uveitis-atypical Cogan syndrome[J]. Eur J Ophthalmol, 2015, 26(1): e14-6. http://www.onacademic.com/detail/journal_1000040379400110_a3e9.html
|
[12] |
SANTORO D, VITA G, ROVITO S, et al. Drug-induced TINU syndrome and genetic characterization[J]. Clin Nephrol, 2012, 78(3): 230-236.
|
[13] |
KAWAMATA M, AKIMOTO T, SUGASE T, et al. Tubulointerstitial nephritis and uveitis syndrome: Are drugs offenders or bystanders?[J]. Clin Med Insights Case Rep, 2016, 9: 21-24. http://europepmc.org/articles/PMC4795485/
|
[14] |
REDMON J H, LEVINE K E, LEBOV J, et al. A comparative review: Chronic Kidney Disease of unknown etiology (CKDu) research conducted in Latin America versus Asia[J]. Environ Res, 2021, 192: 110270. DOI: 10.1016/j.envres.2020.110270.
|
[15] |
齐彩云, 许二赫. 托吡酯与其诱导的葡萄膜炎回顾总结[J]. 中国医药, 2020, 15(2): 314-316. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202002039.htm
QI C Y, XU E H. Review of topiramate and uveitis induced by topiramate[J]. China Medicine, 2020, 15(2): 314-316. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202002039.htm
|
[16] |
KWIATKOWSKA E, DOMAÑSKI L, DZIEDZIEJKO V, et al. The mechanism of drug nephrotoxicity and the methods for preventing kidney damage[J]. Int J Mol Sci, 2021, 22(11): 6109. DOI: 10.3390/ijms22116109.
|
[17] |
CLIVE D M, VANGURI V K. The syndrome of tubulointerstitial nephritis with uveitis (TINU) [J]. Am J Kidney Dis, 2018, 72(1): 118-128. doi: 10.1053/j.ajkd.2017.11.013
|
[18] |
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for tubulointerstitial nephritis with uveitis syndrome[J]. Am J Ophthalmol, 2021, 228: 255-261. doi: 10.1016/j.ajo.2021.03.041
|
[19] |
TAN Y, YU F, QU Z, et al. Modified C-reactive protein might be a target autoantigen of TINU syndrome[J]. Clin J Am Soc Nephrol, 2011, 6(1): 93-100. doi: 10.2215/CJN.09051209
|
[20] |
LI C, SU T, CHU R, et al. Tubulointerstitial nephritis with uveitis in Chinese adults[J]. Clin J Am Soc Nephrol, 2014, 9(1): 21-28. doi: 10.2215/CJN.02540313
|
[21] |
HAYASHI A, TAKAHASHI T, UEDA Y, et al. Long-term clinical characteristics and renal prognosis of children with tubulointerstitial nephritis and uveitis syndrome[J]. Pediatr Nephrol, 2021, 36(8): 2319-2325. doi: 10.1007/s00467-021-04956-6
|
[22] |
HEANEY A, MCLOONE E, WILLIAMS M, et al. Tubulointerstitial nephritis and uveitis in Northern Ireland[J]. Eye (Lond), 2022, 36(8): 1645-1650. doi: 10.1038/s41433-021-01677-w
|
[23] |
KOREISHI A F, ZHOU M, GOLDSTEIN D A. Tubulointerstitial nephritis and uveitis syndrome: characterization of clinical features[J]. Ocul Immunol Inflamm, 2021, 29(7-8): 1312-1317. doi: 10.1080/09273948.2020.1736311
|
[24] |
曹赛霞, 李玉慧, 杨书彦, 等. 白塞综合征眼部损害患者的临床及实验室特点分析[J]. 中华全科医学, 2020, 18(5): 717-719, 738. doi: 10.16766/j.cnki.issn.1674-4152.001337
CAO S X, LI Y H, YANG S Y, et al. Analysis of clinical and laboratory characteristics of ocular damage in patients with Behcet's syndrome[J]. Chinese Journal of General Practice, 2020, 18(5): 717-719, 738. doi: 10.16766/j.cnki.issn.1674-4152.001337
|
[25] |
谢长好, 李志军. 系统性红斑狼疮的诊断与治疗[J]. 中华全科医学, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8
XIE C H, LI Z J. Diagnosis and treatment of systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8
|
[26] |
陈欣, 刘红, 金是, 等. IgG4相关性肾病2例报告[J]. 中国临床医学, 2021, 28(6): 1092-1097. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202106034.htm
CHEN X, LIU H, JIN S, et al. gG4-related kidney disease: 2 cases report[J]. Chinese Journal Of Clinical Medicine, 2021, 28(6): 1092-1097. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202106034.htm
|
[27] |
OLIVA-DAMASO N, OLIVA-DAMASO E, PAYAN J. Acute and chronic tubulointerstitial nephritis of rheumatic causes[J]. Rheum Dis Clin North Am, 2018, 44(4): 619-633. http://www.onacademic.com/detail/journal_1000040434251110_c682.html
|
[28] |
VÔ B, YOMBI J C, AYDIN S, et al. TINU-associated Fanconi syndrome: a case report and review of literature[J]. BMC Nephrol, 2018, 19(1): 274. http://www.researchgate.net/profile/Halil_Yildiz/publication/328391102_TINU-associated_Fanconi_syndrome_a_case_report_and_review_of_literature/links/5bcaded0a6fdcc03c796725f/TINU-associated-Fanconi-syndrome-a-case-report-and-review-of-literature.pdf
|
[29] |
CHEVALIER A, DUFLOS C, CLAVE S, et al. Renal prognosis in children with tubulointerstitial nephritis and uveitis syndrome[J]. Kidney Int Rep, 2021, 6(12): 3045-3053.
|
[30] |
PEPPLE K L, LAM D L, FINN L S, et al. Urinary beta2-microglobulin testing in pediatric uveitis: a case report of a 9-year-old boy with renal and ocular sarcoidosis[J]. Case Rep Ophthalmol, 2015, 6(1): 101-105. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395824/pdf/cop-0006-0101.pdf
|